Reverse Phase Protein Arrays for Compound Profiling.

Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer (2009) 9.26

Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks. Cell (2012) 5.92

Targeting the cancer kinome through polypharmacology. Nat Rev Cancer (2010) 3.74

A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers. Clin Proteomics (2010) 3.25

Vemurafenib: the first drug approved for BRAF-mutant cancer. Nat Rev Drug Discov (2012) 3.09

Collecting and organizing systematic sets of protein data. Nat Rev Mol Cell Biol (2006) 1.58

State-based discovery: a multidimensional screen for small-molecule modulators of EGF signaling. Nat Methods (2006) 1.50

Uncovering quantitative protein interaction networks for mouse PDZ domains using protein microarrays. J Am Chem Soc (2006) 1.40

Profiling receptor tyrosine kinase activation by using Ab microarrays. Proc Natl Acad Sci U S A (2003) 1.36

Dissecting protein function and signaling using protein microarrays. Curr Opin Chem Biol (2009) 1.34

Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays. Oncogene (2012) 1.10

Receptor tyrosine kinases fall into distinct classes based on their inferred signaling networks. Sci Signal (2013) 1.10

Narrative review: BRAF opens the door for therapeutic advances in melanoma. Ann Intern Med (2010) 1.05

Lysate microarrays enable high-throughput, quantitative investigations of cellular signaling. Mol Cell Proteomics (2011) 1.05

A dual array-based approach to assess the abundance and posttranslational modification state of signaling proteins. Sci Signal (2012) 0.90